Alvotech (ALVO) stock
ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.37−0.04 (-0.79%)
Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –
Alvotech operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was 13.3%, against 14.2% the year before. The highest annual figure on record is 14.2% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13.3% | −0.9 |
| FY2024 | Dec 31, 2024 | 14.2% | +402.3 |
| FY2023 | Dec 31, 2023 | -388.1% | +29.1 |
| FY2022 | Dec 31, 2022 | -417.3% | +223.1 |
| FY2021 | Dec 31, 2021 | -640.3% | −433.9 |
| FY2020 | Dec 31, 2020 | -206.5% | – |
See a number that looks wrong?